Aspirin-taking Cardiac Patients can Use Acid Blockers to Prevent Side-effects

by Rajashri on August 13, 2008 at 3:04 PM
 Aspirin-taking Cardiac Patients can Use Acid Blockers to Prevent Side-effects

Adding a stomach acid-blocking drug to the daily routines of patients with clogged heart arteries, who regularly take aspirin to prevent a cardiac event, may protect them against upper gastrointestinal bleeding, an Indian-origin scientist has suggested.

Dr. Sameer Dev Saini, a clinical lecturer in the Division of Gastroenterology at the U-M Medical School, says that proton pump inhibitors (PPIs) are cost-effective for elderly patients, and patients high risk for upper GI bleeding.


"Our study was also able to demonstrate that, for patients at an average risk for GI bleeding, starting PPI cotherapy at a younger age was marginally cost-effective, while starting PPI cotherapy at an older age was highly cost effective. Ultimately, physicians should discuss the gastrointestinal risks of low-dose aspirin with their patients and consider PPI cotherapy," said Saini.

Saini said that PPIs were not regularly prescribed to aspirin-taking coronary heart disease patients, but insisted that taking them on a daily basis could reduce a patient's risk for upper GI bleeding.

"Many Americans are currently taking low-dose aspirin for coronary heart disease, and we know that PPIs are effective in reducing ulcer bleeding in patients on aspirin. What we didn't know, however, was whether it is worth paying for these drugs for patients on low-dose aspirin who had no other risk factors," said Saini.

Results of the study appeared in the latest issue of Archives of Internal Medicine.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Could Baricitinib, an Arthritis Drug, Treat Type 1 Diabetes?
The drug baricitinib can safely and effectively maintain the body's natural insulin production while inhibiting the advancement of Type 1 diabetes.
Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Aspirin-taking Cardiac Patients can Use Acid Blockers to Prevent Side-effects Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests